The Future of Resveratrol |
||
|---|---|---|
|
Breast Cancer - How to Succeed The Victory Garden Is There a Wrong Way to Wash your Hair? Who Is At Risk For Osteoporosis? Weight Loss Surgery: What You Need To Know Before You Go Under the Knife The Natural Vitamin Supplement Option Water: the Importance of it and Recommended Amount Get Flat Stomach in 10 Days Tv's Team Approach Motivates Weight Loss Full Body Massage: a Great Form of Physical and Mental Therapy |
Resveratrol is a natural product that is found in a number of substances, including the grapes used to make red wine. This product has a lot of hype surrounding it and has done for several years now. This doesn’t really come as any surprise for the fact the product has been associated with a number of health benefits for a while now such as weight loss, anti-aging and the prevention of disease such as cancers. Many if not most of the benefits associated with resveratrol have been looked into at Harvard university in the UK, with a lot of interest and study coming from Dr. David Sinclair. The interest in the studies that Dr. Sinclair and other Dr’s carried out at Harvard University quickly became immense as the substance resveratrol proved to be a key substitute in the hope of finding a cure for type 2 diabetes. One company in particular picked up on this, Glaxo, known fully as GlaxoSmithKline plc. They are a UK based pharmaceutical, biological and healthcare company who are responsible for Alli; the first clinically proven over the counter weight loss aid that is now available in pharmacies across Europe. It was Glaxo who went on to purchase the resveratrol studies undertaken at Harvard, which included a company known as Sirtris, which Dr. Sinclair was the co-founder of. Glaxo agreed this at a price of roughly 770 million. Sirtris was in the process of undergoing trials of using resveratrol in drugs designed to expand the human lifespan. They also had a drug in clinical trials that was being tested against type 2 diabetes, which is what sparked Glaxo’s interest in the research being carried out at Harvard in the first place. Diabetes is one of the many diseases that is associated with aging that the company wants to prevent. They believe that such an impact on health would be a breakthrough and open the door to other cures. It certainly would be a breakthrough considering diabetes is a potentially fatal disease; in fact studies showed that over 100 people a day die from the disease. The purchase of Harvard studies as well as the company Sirtris was welcomed by both parties. The reason being is Sirtris was focused on developing drugs that activate what are known as sirtuins, which are a class of enzymes to do with aging. So where does resveratrol fit into this? Well the most advanced compounds of these enzymes is the formulation of resveratrol. Resveratrol is known and highly sought after due to its high number of antioxidants, which are one of the reasons why it is important to the work of tackling disease such as diabetes. By Glaxo purchasing the study associated with resveratrol it has opened them up to a new area of research that otherwise may not have been funded. The substance plays such an important part in our future for the fact it has the potential to aid in the fight of not only diabetes but also muscle wasting and neurodegeneration. This is certainly not the last we are going to be seeing and hearing of resveratrol, in fact it could be the beginning of a new chapter in the medical books. |
|